Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
about
Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control studyAndrogens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproductionAndrogens (dehydroepiandrosterone or testosterone) in women undergoing assisted reproductionThe role of autoimmunity in premature ovarian failureDehydroepiandrosterone as an adjunct to gonadotropins in infertile Indian women with premature ovarian aging: A pilot studyDehydroepiandrosterone: A panacea for the ageing ovary?Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysisDefining ovarian reserve to better understand ovarian agingAssociation of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/raceEffect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria.Basal serum testosterone levels correlate with ovarian response but do not predict pregnancy outcome in non-PCOS women undergoing IVF.The "graying" of infertility services: an impending revolution nobody is ready for.Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.Efficacy of dehydroepiandrosterone to overcome the effect of ovarian ageing (DITTO): a proof of principle randomised controlled trial protocol.Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial.Impact of dehydroepiandrosterone on clinical outcome in poor responders: A pilot study in women undergoing in vitro fertilization, using bologna criteria.Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcomeDehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years oldThe role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilizationLessons from elective in vitro fertilization (IVF) in, principally, non-infertile women.Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled triaDoes hormonal contraception prior to in vitro fertilization (IVF) negatively affect oocyte yields? A pilot study.The Concepts and Consequences of Early Ovarian Ageing: A Caveat to Women's HealthIs there a role for DHEA supplementation in women with diminished ovarian reserve?Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition.Electroacupuncture for reproductive hormone levels in patients with diminished ovarian reserve: a prospective observational study.Low testosterone levels in women with diminished ovarian reserve impair embryo implantation rate: a retrospective case-control studyAndrogens, health and sexuality in women and men.What is the role of assisted reproduction technology in the management of age-related infertility?British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice.A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection.Association of basal serum androgen levels with ovarian response and ICSI cycle outcome.The impact of FMR1 gene mutations on human reproduction and development: a systematic review.Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders.
P2860
Q21245539-9EE90B92-EB36-4A9A-A424-00561C70A6FBQ21245546-B153175D-6006-4982-B1BE-59967F81440FQ24187619-2966A3E6-72C8-4D47-9C59-31F15DFB3D20Q24201562-FAF8E4A6-A8BD-4BBC-9933-9F3E66260F42Q26777105-5028A933-E801-448D-94B6-A8C7AA4EC88FQ26779878-3ECBFEA4-5193-4FBE-AEB2-40A07763BF68Q26796533-9DB4BB8E-9ACB-4D77-A859-53AC7844759CQ27028043-AD25B944-4930-4982-BCB8-DE5BEA656189Q28386414-DC3F1D1C-3B5F-4C4E-B013-B6940738D6C0Q28740984-86F4E82B-FB5C-4CD5-A8E5-DDFB438CFB60Q33763516-C573DE9C-2F46-415F-9967-90F12DE8A764Q33897193-588444FD-3910-4F75-B02C-F0027C0110FBQ33929556-07990BEC-02AE-41F6-B9D0-B753D9BFF63AQ33952002-0014EB82-3306-4D31-9298-6FF077F9DCDDQ34009340-683F8F26-364E-4615-8014-287CE6F4AF1DQ34327502-831C84EA-2E0F-4524-B485-EAF21AC62703Q34409970-40D6C813-2F47-4A82-93C9-EAAEA5974AB8Q34500280-AD981E16-8D4E-4BED-B31A-66F4D0D028F0Q34540908-F37A8F8F-F62B-46A0-A993-9F484086F9B9Q35038490-5630EDDB-700B-40A8-BC72-F1EA4EB69324Q35166531-6C5C0FF9-1AB5-49CF-AEE6-74348CC6D911Q35206247-455F8AB7-9228-4DF2-9BEF-736E330D0667Q35994080-9B097508-494C-4565-BECD-033DEF5B6FFFQ36165407-A67656C2-8464-4123-9C5A-E688B45F39F8Q36390581-CC8594EF-7ECB-430E-8400-87E773FC11E6Q36557314-EA709B4A-64D4-4B67-9C7D-0235DFAF308AQ36583935-0539EDF6-DF7C-4593-98B0-B15D2C5883F7Q36797854-36F69B02-CC17-4E34-93BA-9C83E9A4B25FQ37035370-C64B1879-3353-4C4E-AE03-95F077925C75Q37239561-0ACD1CFA-5538-44B3-BF2A-15022E50D3B8Q37315769-03504C85-FFC6-4EA4-AED5-F947247F93D8Q37398848-F9AA2E61-A5C9-42FE-BBB6-4BDA1E0AB160Q37671831-88B8EFE8-8591-4D92-AE0B-951F6E2317C4Q37813672-4F485334-FAA7-4593-84D0-25133A9FAC09Q37844160-0381A396-EC33-40DC-86E8-18C2F6404338Q38297114-5E285E0F-2E64-43E9-8AA3-449945D8948CQ38595676-AB5811DD-023A-414D-BD43-92CAEF86798FQ38661105-ED95DAA8-A996-465B-BAA1-8031CE7F3C0BQ38901729-DCA2B727-1EEA-46B7-B339-64030FEF62F3Q39031773-CB4A3A0E-CD9D-455F-B5E6-052B1312B348
P2860
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Update on the use of dehydroep ...... h diminished ovarian function.
@ast
Update on the use of dehydroep ...... h diminished ovarian function.
@en
type
label
Update on the use of dehydroep ...... h diminished ovarian function.
@ast
Update on the use of dehydroep ...... h diminished ovarian function.
@en
prefLabel
Update on the use of dehydroep ...... h diminished ovarian function.
@ast
Update on the use of dehydroep ...... h diminished ovarian function.
@en
P2093
P2860
P1476
Update on the use of dehydroep ...... h diminished ovarian function.
@en
P2093
David Barad
Hyama Brill
Norbert Gleicher
P2860
P2888
P304
P356
10.1007/S10815-007-9178-X
P577
2007-12-11T00:00:00Z